Addex Therapeutics Ltd.
August 27, 2024 - by Joey Ramson
$ADXN gapped up today and is leading the Prism MarketView Biotech index after Addex Therapeutics and Indivior ($INDV) announced that they have selected clinical candidates from their GABAB-positive allosteric modulator (PAM) research collaboration.
